Established | 2010 |
---|---|
Focus | developmental biology, epigenetics, DNA repair, ageing |
Location | , |
Website | www.imb-mainz.de |
The Institute of Molecular Biology (IMB) is a modern research centre on the campus of the Johannes Gutenberg University in Mainz, Germany. It is funded by the Boehringer Ingelheim Foundation and the state of Rheinland Palatinate. The scientists at IMB primarily conduct basic science in developmental biology, epigenetics, ageing, genome stability and related areas. [1]
IMB's mission is to answer key questions in how organisms grow, age, and develop disease through basic research in epigenetics, genome stability and related fields.
Research in these fields is carried out in the following research groups, led by one group leader each:
IMB coordinates a number of joint research initiatives with institutions in Mainz (Johannes Gutenberg University, the University Medical Centre, and the Max Planck Institute for Polymer Research) and beyond.
Current joint Research Initiatives:
In addition, IMB runs an Advanced Training Programme with short courses in soft skills.
The International PhD Program is coordinated by the Institute for Molecular Biology. The participating groups are located at the following institutions:
The research groups in the IPP cover a broad range of expertise in ageing & disease, DNA repair & genome stability, epigenetics & nuclear dynamics, bioinformatics & computational biology, RNA biology, and gene regulation & evolution.
Core funding for the IPP comes from the three main participating institutions of IMB, JGU, and UMC.
The International Summer School (ISS) is a 6-week programme with a focus on "Gene Regulation, Epigenetics and Genome Stability". The ISS offers outstanding and enthusiastic undergraduate and Master's students from all over the world the opportunity to acquire excellent practical skills and hands-on training from leading scientists in molecular biology.
The IMB Postdoc Programme (IPPro) was established specifically to provide IMBs postdocs with the necessary scientific & technical support and tailored mentoring to fast-track their careers, including scientific seminars, courses & events, technical training, professional skills training, mentoring, and career development.
Current members of the SAB:
IMB is housed in a new 6,000 sq m research building with laboratories, offices, seminar rooms and a large auditorium. IMB is located in close proximity to many institutes of the Johannes Gutenberg University of Mainz, two Max Planck Institutes, the University of Applied Sciences Mainz, and the University Medical Center. Nearby Frankfurt and Darmstadt are also cities with extensive scientific activities, including the research of Goethe University Frankfurt, and the Technical University of Darmstadt.
In biology, epigenetics is the study of heritable traits, or a stable change of cell function, that happen without changes to the DNA sequence. The Greek prefix epi- in epigenetics implies features that are "on top of" or "in addition to" the traditional genetic mechanism of inheritance. Epigenetics usually involves a change that is not erased by cell division, and affects the regulation of gene expression. Such effects on cellular and physiological phenotypic traits may result from environmental factors, or be part of normal development. They can lead to cancer.
Arthur Dale Riggs was an American geneticist who worked with Genentech to express the first artificial gene in bacteria. His work was critical to the modern biotechnology industry because it was the first use of molecular techniques in commercial production of drugs and enabled the large-scale manufacturing of protein drugs, including insulin. He was also a major factor in the origin of epigenetics.
Robin Holliday was a British molecular biologist. Holliday described a mechanism of DNA-strand exchange that attempted to explain gene-conversion events that occur during meiosis in fungi. That model first proposed in 1964 and is now known as the Holliday Junction.
The Max Planck Institute (MPI) for Biology of Ageing, founded in 2008, is one of over 80 independent, non-profit-making institutes set up under the umbrella of the Max Planck Society. The overall research aim is to obtain fundamental insights into the aging process and thus to pave the way towards healthier aging in humans. An international research team drawn from almost 30 nations is working to uncover underlying molecular, physiological and evolutionary mechanisms.
The Research Institute of Molecular Pathology (IMP) is a biomedical research center, which conducts curiosity-driven basic research in the molecular life sciences.
The Institute of Molecular Biotechnology (IMBA) is an independent biomedical research organisation founded by the Austrian Academy of Sciences in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research. IMBA is located at the Vienna BioCenter (VBC) and shares facilities and scientific training programs with the Gregor Mendel Institute of Molecular Plant Biology (GMI) of the Austrian Academy of Sciences and the Research Institute of Molecular Pathology (IMP), the basic research center of Boehringer Ingelheim.
An epigenetic clock is a biochemical test that can be used to measure age. The test is based on DNA methylation levels, measuring the accumulation of methyl groups to one's DNA molecules.
The European Research Institute for the Biology of Ageing (ERIBA) is a nonprofit research facility based in Groningen, Netherlands, concerned with cross-disciplinary research on ageing. The institute is part of the University Medical Center Groningen and is funded by the Ministry of Economic Affairs, Agriculture and Innovation, the province of Groningen, Collaboration of the Northern Netherlands (SNN), the European Union, the Noaber Foundation and the Pediatric Oncology Foundation Groningen. The total sum granted was €3.95M in 2011 and €7.4M in 2012. The main building was designed by Rudy Uytenhaak Architectenbureau.
Ashok Venkitaraman is a British cancer researcher of Indian origin. He is the Director of the Cancer Science Institute of Singapore, a Distinguished Professor of Medicine at the National University of Singapore, and Program Director at A*STAR, Singapore. From 1998 to 2020, he was the inaugural holder of the Ursula Zoellner Professorship of Cancer Research at the University of Cambridge, a Professorial Fellow at Pembroke College, Cambridge, and from 2006 to 2019, was the Director of the Medical Research Council Cancer Unit
Elizabeth Salisbury Dennis is an Australian scientist working mainly in the area of plant molecular biology. She is currently a chief scientist at the plant division of CSIRO Canberra. She was elected a Fellow of the Australian Academy of Technological Sciences and Engineering (FTSE) in 1987, and the Australian Academy of Science in 1995. She jointly received the inaugural Prime Minister's Science Prize together with Professor Jim Peacock in 2000 for her outstanding achievements in science and technology.
Robert Anthony Martienssen is a British plant biologist, Howard Hughes Medical Institute–Gordon and Betty Moore Foundation investigator, and professor at Cold Spring Harbor Laboratory, US.
Max Luciano Birnstiel was a Swiss molecular biologist who held a number of positions in scientific leadership in Europe, including the chair of the Institute of Molecular Biology at the University of Zurich from 1972–86, and that of founding director of the Research Institute of Molecular Pathology (IMP) in Vienna from 1986 to 1996. His research focused on gene regulation in eukaryotes. His research group is sometimes cited as the first to purify single genes, the ribosomal RNA genes from Xenopus laevis, three years before the successful isolation of the lac operon. He is also recognized for one of the earliest discoveries of a gene enhancer element. Birnstiel died in 2014 of heart failure during cancer treatment.
Kathy Niakan is a developmental biologist, working in human developmental and stem cell biology. In 2016 she became the first scientist in the world to gain regulatory approval to edit the genomes of human embryos for research.
Bernd Kaina, born on 7 January 1950 in Drewitz, is a German biologist and toxicologist. His research is devoted to DNA damage and repair, DNA damage response, genotoxic signaling and cell death induced by carcinogenic DNA damaging insults.
Amparo Acker-Palmer is a German-based Spanish cell biologist and neuroscientist. Her research focuses on the similarities of the mechanism of nerve and blood vessel development. She has worked alongside her husband, Till Acker, who is a neurobiologist, in researching tumor therapies. In her career, she has won several awards, including the Paul Ehrlich & Ludwig Darmstaeder Prize for Young Researchers in 2010. In 2012, Amparo Acker-Palmer was elected as member of the German Academy of Sciences Leopoldina.
Anne Carla Ferguson-Smith is a mammalian developmental geneticist. She is the Arthur Balfour Professor of Genetics and Pro-Vice Chancellor for Research and International Partnerships at the University of Cambridge. Formerly head of the Department of Genetics at the University of Cambridge, she is a Fellow of Darwin College, Cambridge and serves as President of the Genetics Society.
Thomas Jenuwein is a German scientist working in the fields of epigenetics, chromatin biology, gene regulation and genome function.
Ana Pombo is an appointed Professor (W3) of Biology at Humboldt University and senior group leader at the Berlin Institute for Medical Systems Biology (BIMSB) at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin-Buch with the focus on "Epigenetic Regulation and Chromatin Architecture". Since May 2018, Pombo is an elected member of the European Molecular Biology Organization (EMBO).
Isabelle M. Mansuy is a professor in neuroepigenetics in the Medical Faculty of the University of Zurich and the Department of Health Science and Technology of the Swiss Federal Institute of Technology Zurich. She is known for her work on the mechanisms of epigenetic inheritance in relation to childhood trauma.
Thomas Boehm is a German immunologist. He is a Director of the Max Planck Institute for Immunobiology and Epigenetics in Freiburg im Breisgau. He has won a variety of prizes for his research work.
{{cite web}}
: Missing or empty |title=
(help)